TS Financial Group (TSFG)’s Biogen BIIB Stock Holding History

TS Financial Group (TSFG)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5	Closed	-$1K	–	773
2023 Q4	$1K	Sell	5 -4	-44%	-$982	﹤0.01%	773
2023 Q3	$2K	Hold	9	–	–	﹤0.01%	805
2023 Q2	$3K	Buy	9 +2	+29%	+$595	﹤0.01%	736
2023 Q1	$2K	Hold	7	–	–	﹤0.01%	797
2022 Q4	$2K	Hold	7	–	–	﹤0.01%	790
2022 Q3	$2K	Sell	7 -37	-84%	-$7.86K	﹤0.01%	763
2022 Q2	$9K	Hold	44	–	–	﹤0.01%	540
2022 Q1	$9K	Hold	44	–	–	﹤0.01%	551
2021 Q4	$11K	Buy	44 +39	+780%	+$10K	﹤0.01%	545
2021 Q3	$1K	Hold	5	–	–	﹤0.01%	790
2021 Q2	$2K	Hold	5	–	–	﹤0.01%	731
2021 Q1	$1K	Hold	5	–	–	﹤0.01%	707
2020 Q4	$1K	Hold	5	–	–	﹤0.01%	807
2020 Q3	$1K	Hold	5	–	–	﹤0.01%	724
2020 Q2	$1K	Hold	5	–	–	﹤0.01%	710
2020 Q1	$2K	Hold	5	–	–	﹤0.01%	575
2019 Q4	$1K	Hold	5	–	–	﹤0.01%	684
2019 Q3	$1K	Sell	5 -50	-91%	-$11.6K	﹤0.01%	695
2019 Q2	$13K	Hold	55	–	–	0.01%	359
2019 Q1	$13K	Buy	+55	New	+$17.3K	0.01%	351

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TS Financial Group (TSFG)'s BIIB Position: Q1 2024 in Review

TS Financial Group (TSFG) sold out of Biogen (BIIB) in Q1 2024, closing a stake of 5 shares — an estimated $1K sold.

TS Financial Group (TSFG) first reported a position in BIIB in Q1 2019 and held it in 20 quarters. The position peaked at $13K in Q2 2019. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

TS Financial Group (TSFG) reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
TS Financial Group (TSFG) sold 5 Biogen shares in Q1 2024, an estimated $1K.
TS Financial Group (TSFG) first reported a position in Biogen in Q1 2019 and held it in 20 quarters.
TS Financial Group (TSFG)'s Biogen position peaked at $13K in Q2 2019.
955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on TS Financial Group (TSFG)'s 13F filing for Q1 2024, filed 16 Apr 2024.